VanEck Associates’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,524
Closed -$442K 850
2018
Q3
$442K Buy
9,524
+545
+6% +$26.4K ﹤0.01% 686
2018
Q2
$433K Buy
8,979
+151
+2% +$7.22K ﹤0.01% 689
2018
Q1
$382K Buy
8,828
+588
+7% +$26.4K ﹤0.01% 598
2017
Q4
$327K Sell
8,240
-496
-6% -$20.7K ﹤0.01% 601
2017
Q3
$379K Buy
8,736
+390
+5% +$17.8K ﹤0.01% 592
2017
Q2
$399K Buy
8,346
+64
+0.8% +$2.98K ﹤0.01% 587
2017
Q1
$340K Hold
8,282
﹤0.01% 633
2016
Q4
$318K Buy
8,282
+164
+2% +$6.66K ﹤0.01% 627
2016
Q3
$436K Buy
8,118
+30
+0.4% +$1.39K ﹤0.01% 590
2016
Q2
$348K Sell
8,088
-862
-10% -$36.2K ﹤0.01% 590
2016
Q1
$452K Buy
8,950
+51
+0.6% +$2.45K ﹤0.01% 538
2015
Q4
$563K Sell
8,899
-515
-5% -$35.1K ﹤0.01% 460
2015
Q3
$616K Buy
9,414
+1,203
+15% +$79.8K ﹤0.01% 438
2015
Q2
$556K Buy
8,211
+1,978
+32% +$109K ﹤0.01% 485
2015
Q1
$266K Sell
6,233
-446
-7% -$19.8K ﹤0.01% 557
2014
Q4
$330K Sell
6,679
-3,161
-32% -$127K ﹤0.01% 528
2014
Q3
$283K Buy
9,840
+915
+10% +$24.8K ﹤0.01% 568
2014
Q2
$234K Buy
8,925
+2,191
+33% +$56.6K ﹤0.01% 590
2014
Q1
$375K Buy
6,734
+1,398
+26% +$80.4K ﹤0.01% 513
2013
Q4
$257K Buy
5,336
+1,034
+24% +$43.5K ﹤0.01% 535
2013
Q3
$181K Buy
4,302
+2,286
+113% +$109K ﹤0.01% 555
2013
Q2
$91K Buy
+2,016
New +$79K ﹤0.01% 607

Other funds holding IMPV

VanEck Associates's IMPV Position: Q4 2018 in Review

VanEck Associates sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 9,524 shares — an estimated $442K sold.

VanEck Associates first reported a position in IMPV in Q2 2013 and held it in 22 quarters. The position peaked at $616K in Q3 2015. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • VanEck Associates reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • VanEck Associates sold 9,524 Imperva, Inc. shares in Q4 2018, an estimated $442K.
  • VanEck Associates first reported a position in Imperva, Inc. in Q2 2013 and held it in 22 quarters.
  • VanEck Associates's Imperva, Inc. position peaked at $616K in Q3 2015.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on VanEck Associates's 13F filing for Q4 2018, filed 12 Feb 2019.